Divergent Wealth Advisors Eli Lilly & CO Transaction History

Divergent Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 07, 2023	BUY	$350.74 - $468.98 $1,052 - $1,406	3 Added 0.25%	1,197 $561,000
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.42%	1,194 $410,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $382,322 - $445,482	1,189 New	1,189 $434,000
Q4 2020 Jan 22, 2021	SELL	$130.46 - $172.63 $303,189 - $401,192	-2,324 Closed	0 $0
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $172,464 - $203,582	2,324 New	2,324 $180,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Divergent Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Divergent Wealth Advisors with notifications on news.